ProAssurance Corporation (NYSE:PRA – Get Free Report) has been assigned a consensus rating of “Reduce” from the six brokerages that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation and five have assigned a hold recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $25.00.
PRA has been the subject of several analyst reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of ProAssurance in a report on Wednesday, October 8th. Wall Street Zen upgraded shares of ProAssurance to a “sell” rating in a research report on Saturday, November 22nd. Finally, Zacks Research cut shares of ProAssurance from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 5th.
Get Our Latest Analysis on ProAssurance
Institutional Investors Weigh In On ProAssurance
ProAssurance Stock Performance
NYSE PRA opened at $24.26 on Friday. The firm has a market capitalization of $1.25 billion, a P/E ratio of 37.32 and a beta of 0.11. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.32. The firm’s fifty day moving average price is $24.03 and its two-hundred day moving average price is $23.75. ProAssurance has a 1 year low of $13.90 and a 1 year high of $24.41.
ProAssurance (NYSE:PRA – Get Free Report) last released its quarterly earnings data on Friday, May 20th. The insurance provider reported $0.04 earnings per share (EPS) for the quarter. The firm had revenue of $220.02 million for the quarter. ProAssurance had a return on equity of 4.78% and a net margin of 3.01%. As a group, research analysts anticipate that ProAssurance will post 0.8 EPS for the current year.
ProAssurance Company Profile
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
Featured Stories
- Five stocks we like better than ProAssurance
- What is MarketRank� How to Use it
- Synopsys Sees Bullish Shift as Ansys Integration Drives Growth
- Compound Interest and Why It Matters When Investing
- The Best Holiday Present You Can Give Yourself? Costco Stock
- How to Invest in Small Cap StocksĀ
- Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff
Receive News & Ratings for ProAssurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProAssurance and related companies with MarketBeat.com's FREE daily email newsletter.
